PMC:7534795 / 32767-33808
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T166 | 181-186 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T167 | 206-227 | Body_part | denotes | cardiovascular system | http://purl.org/sig/ont/fma/fma7161 |
T168 | 284-289 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T169 | 313-324 | Body_part | denotes | fatty acids | http://purl.org/sig/ont/fma/fma82738 |
T170 | 335-342 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T171 | 528-533 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T172 | 920-925 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T58 | 206-227 | Body_part | denotes | cardiovascular system | http://purl.obolibrary.org/obo/UBERON_0004535 |
T59 | 284-289 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T258 | 83-101 | Disease | denotes | SARS-CoV infection | http://purl.obolibrary.org/obo/MONDO_0005091 |
T259 | 92-101 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T260 | 258-272 | Disease | denotes | hyperlipidemia | http://purl.obolibrary.org/obo/MONDO_0021187 |
T261 | 457-465 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T262 | 470-478 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T263 | 643-651 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T264 | 702-710 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T265 | 1032-1040 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T33652 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T84691 | 206-227 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | cardiovascular system |
T4742 | 206-227 | http://www.ebi.ac.uk/efo/EFO_0000791 | denotes | cardiovascular system |
T58635 | 604-605 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T95845 | 759-760 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6069 | 785-786 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T250 | 181-186 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T251 | 313-324 | Chemical | denotes | fatty acids | http://purl.obolibrary.org/obo/CHEBI_35366 |
T252 | 319-324 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
T253 | 335-342 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T255 | 528-533 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T256 | 543-550 | Chemical | denotes | statins | http://purl.obolibrary.org/obo/CHEBI_87631 |
T257 | 731-738 | Chemical | denotes | statins | http://purl.obolibrary.org/obo/CHEBI_87631 |
T258 | 920-940 | Chemical | denotes | lipid-lowering drugs | http://purl.obolibrary.org/obo/CHEBI_35679 |
T259 | 920-925 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T260 | 935-940 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T81 | 181-197 | http://purl.obolibrary.org/obo/GO_0006629 | denotes | lipid metabolism |
T82 | 187-197 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T83 | 335-353 | http://purl.obolibrary.org/obo/GO_0006006 | denotes | glucose metabolism |
T84 | 343-353 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T85 | 807-828 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory response |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T234 | 0-228 | Sentence | denotes | A 12-year follow-up study conducted by Wu et al. of 25 patients who recovered from SARS-CoV infection demonstrated patients were affected by various metabolic disturbances altering lipid metabolism and the cardiovascular system. |
T235 | 229-411 | Sentence | denotes | These patients suffered from hyperlipidemia, increased serum concentrations of free fatty acids, abnormal glucose metabolism and other cardiovascular abnormalities (Wu et al., 2017). |
T236 | 412-652 | Sentence | denotes | Considering the genetic similarities between SARS-CoV and SARS-CoV-2, Zhang et al. recently proposed the use of the lipid-lowering statins, which also possess anti-inflammatory properties, as a therapeutic option for patients with COVID-19. |
T237 | 653-891 | Sentence | denotes | This study reported that amongst 13,981 cases of COVID-19, in-hospital use of statins was associated with a lower risk of death and a significantly lower inflammatory response during the entire hospitalization period (Zhang et al., 2020). |
T238 | 892-1041 | Sentence | denotes | Thus, suggesting the use of lipid-lowering drugs with anti-inflammatory properties can improve the cardiovascular outcomes in patients with COVID-19. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T136 | 258-272 | Phenotype | denotes | hyperlipidemia | http://purl.obolibrary.org/obo/HP_0003077 |
T137 | 313-334 | Phenotype | denotes | fatty acids, abnormal | http://purl.obolibrary.org/obo/HP_0004359 |
T138 | 364-392 | Phenotype | denotes | cardiovascular abnormalities | http://purl.obolibrary.org/obo/HP_0001626 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
33031856-28831119-84038873 | 405-409 | 28831119 | denotes | 2017 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1070 | 55-63 | Species | denotes | patients | Tax:9606 |
1071 | 115-123 | Species | denotes | patients | Tax:9606 |
1072 | 235-243 | Species | denotes | patients | Tax:9606 |
1073 | 457-465 | Species | denotes | SARS-CoV | Tax:694009 |
1074 | 470-480 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1077 | 181-186 | Chemical | denotes | lipid | MESH:D008055 |
1078 | 313-324 | Chemical | denotes | fatty acids | MESH:D005227 |
1079 | 528-533 | Chemical | denotes | lipid | MESH:D008055 |
1080 | 83-101 | Disease | denotes | SARS-CoV infection | MESH:C000657245 |
1081 | 258-272 | Disease | denotes | hyperlipidemia | MESH:D006949 |
1082 | 326-353 | Disease | denotes | abnormal glucose metabolism | MESH:D044882 |
1083 | 364-392 | Disease | denotes | cardiovascular abnormalities | MESH:D002318 |